The Diagnosis-Organized Psychiatric Prescribing Reference That Belongs on Every Prescriber's Desk
Most psychopharmacology references are organized by drug class. That structure works in a classroom. It fails in a 15-minute medication management appointment when a patient is sitting across from you describing treatment-resistant depression and you need an evidence-based decision tree, not a chapter on SSRIs. This clinical guide is organized by diagnosis and patient presentation, so you go from the clinical question directly to the prescribing answer.
Built for How Prescribers Actually Work
Every chapter follows the same architecture: diagnostic confirmation, first-line medication selection matched to symptom profile, augmentation strategies for partial response, treatment-resistant pathways, and monitoring parameters embedded at every decision point. Decision trees walk you through each branch. Icons flag black box warnings, off-label use, pregnancy considerations, pharmacogenomic alerts, and cost concerns at a glance. Cross-references connect comorbid presentations so you never have to guess which chapter addresses your patient's complex needs.
Current Through 2025 FDA Approvals and Practice Guidelines
This guide integrates the most recent clinical developments including esketamine monotherapy for treatment-resistant depression, Cobenfy (the first non-dopaminergic antipsychotic), lumateperone for adjunctive MDD treatment, the 2025 benzodiazepine tapering guideline from ten medical societies, clozapine REMS elimination, the updated PTSD psychopharmacology algorithm, and new APA delirium guidelines. Pharmacogenomic prescribing guidance with CPIC dosing recommendations is woven throughout, not isolated in a single chapter.
26 Chapters Covering Every Major Psychiatric Diagnosis
From major depressive disorder and bipolar spectrum to anxiety disorders, PTSD, psychotic disorders, ADHD, substance use disorders, eating disorders, neurocognitive disorders, and personality disorders. Dedicated chapters address perinatal prescribing, pediatric psychopharmacology, geriatric considerations, medical comorbidity adjustments, and psychiatric emergencies. Six appendices provide dosing tables, benzodiazepine equivalency charts, black box warning summaries, new medication profiles, pharmacogenomic reference tables, and clinical resource directories.
Designed for PMHNPs and Advanced Practice Providers
This reference was built for psychiatric mental health nurse practitioners, physician assistants, psychiatric residents, and primary care providers managing psychiatric medications. It is the affordable, portable, diagnosis-organized alternative to drug-class references that cost twice as much and take twice as long to find what you need during a clinical encounter.
